The main difference lies in how they work in the body: Semaglutide : Targets the GLP-1 receptor only, enhancing the bodys natural fullness signals and slowing digestion
Your Personal Roadmap No two journeys look alike: Personalized medicine research emphasizes that your genetics, your history, your lifestyle, your support system everything influences what approach works best for you
If you administer subcutaneous injections regularly, such as once or multiple times daily, you will need to rotate the injection sites
It mimics a hormone your body naturally produces when you eat, which triggers your pancreas to release insulin when blood sugar rises
Most recently, results from the FLOW trial found that the GLP-1 Ozempic can slow the progression of kidney disease and reduce the risk of death from kidney or cardiovascular events
Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK